Stockreport

Sonnet BioTherapeutics regains compliance with Nasdaq [Seeking Alpha]

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF The Co.'s securities may be delisted from Nasdaq if, within one-year monitoring period, the Nasdaq finds the Co. again out of compliance with the Bid Price Rule 5810(c) [Read more]